PRESS RELEASE published on 02/08/2023 at 14:30, 3 years ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 3 years ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 3 years ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 3 years ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 3 years 1 month ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 3 years 1 month ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 3 years 1 month ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 3 years 1 month ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
PRESS RELEASE published on 01/20/2023 at 18:45, 3 years 1 month ago Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
PRESS RELEASE published on 01/20/2023 at 14:30, 3 years 1 month ago Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
Published on 02/28/2026 at 03:00, 6 hours 21 minutes ago Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 7 hours 21 minutes ago Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 9 hours 11 minutes ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/27/2026 at 23:30, 9 hours 51 minutes ago 55 North Mining Announces Closing of Flow-Through Financing
Published on 02/27/2026 at 17:59, 15 hours 22 minutes ago EQS-Adhoc: 4finance completes sale of TBI Bank to Advent International
Published on 02/27/2026 at 17:33, 15 hours 48 minutes ago 4finance Holding S.A. reports results for the year ending 31 December 2025
Published on 02/27/2026 at 23:00, 10 hours 21 minutes ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 15 hours 18 minutes ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 15 hours 36 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 15 hours 36 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
Published on 02/27/2026 at 08:45, 1 day ago Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium
